PMID- 28410006 OWN - NLM STAT- MEDLINE DCOM- 20180329 LR - 20200403 IS - 1554-8635 (Electronic) IS - 1554-8627 (Print) IS - 1554-8627 (Linking) VI - 13 IP - 5 DP - 2017 May 4 TI - Chaperone-mediated autophagy prevents cellular transformation by regulating MYC proteasomal degradation. PG - 928-940 LID - 10.1080/15548627.2017.1293767 [doi] AB - Chaperone-mediated autophagy (CMA), a selective form of protein lysosomal degradation, is maximally activated in stress situations to ensure maintenance of cellular homeostasis. CMA activity decreases with age and in several human chronic disorders, but in contrast, in most cancer cells, CMA is upregulated and required for tumor growth. However, the role of CMA in malignant transformation remains unknown. In this study, we demonstrate that CMA inhibition in fibroblasts augments the efficiency of MYC/c-Myc-driven cellular transformation. CMA blockage contributes to the increase of total and nuclear MYC, leading to enhancement of cell proliferation and colony formation. Impaired CMA functionality accentuates tumorigenesis-related metabolic changes observed upon MYC-transformation. Although not a direct CMA substrate, we have found that CMA regulates cellular MYC levels by controlling its proteasomal degradation. CMA promotes MYC ubiquitination and degradation by regulating the degradation of C330027C09Rik/KIAA1524/CIP2A (referred to hereafter as CIP2A), responsible for MYC stabilization. Ubiquitination and proteasomal degradation of MYC requires dephosphorylation at Ser62, and CIP2A inhibits the phosphatase responsible for this dephosphorylation. Failure to degrade CIP2A upon CMA blockage leads to increased levels of phosphorylated MYC (Ser62) and to stabilization of this oncogene. We demonstrate that this phosphorylation is essential for the CMA-mediated effect, since specific mutation of this site (Ser62 to Ala62) is enough to normalize MYC levels in CMA-incompetent cells. Altogether these data demonstrate that CMA mitigates MYC oncogenic activity by promoting its proteasomal degradation and reveal a novel tumor suppressive role for CMA in nontumorigenic cells. FAU - Gomes, Luciana R AU - Gomes LR AD - a Department of Developmental and Molecular Biology and Institute for Aging Studies , Albert Einstein College of Medicine , Bronx , NY , USA. AD - b Department of Microbiology , Institute of Biomedical Sciences, University of Sao Paulo , Sao Paulo , SP , Brazil. FAU - Menck, Carlos F M AU - Menck CFM AD - b Department of Microbiology , Institute of Biomedical Sciences, University of Sao Paulo , Sao Paulo , SP , Brazil. FAU - Cuervo, Ana Maria AU - Cuervo AM AD - a Department of Developmental and Molecular Biology and Institute for Aging Studies , Albert Einstein College of Medicine , Bronx , NY , USA. LA - eng GR - P30 DK041296/DK/NIDDK NIH HHS/United States GR - R37 AG021904/AG/NIA NIH HHS/United States GR - P30 DK020541/DK/NIDDK NIH HHS/United States GR - P30 AG038072/AG/NIA NIH HHS/United States GR - R01 DK098408/DK/NIDDK NIH HHS/United States GR - P01 AG031782/AG/NIA NIH HHS/United States PT - Journal Article DEP - 20170302 PL - United States TA - Autophagy JT - Autophagy JID - 101265188 RN - 0 (Molecular Chaperones) RN - 0 (Proto-Oncogene Proteins c-myc) SB - IM MH - Animals MH - Autophagy/*physiology MH - Cell Proliferation/*physiology MH - Fibroblasts/metabolism MH - Lysosomes/*metabolism MH - Mice MH - Molecular Chaperones/*metabolism MH - Neoplasms/metabolism MH - Proto-Oncogene Proteins c-myc/metabolism MH - Ubiquitination/physiology PMC - PMC5446085 OTO - NOTNLM OT - Autophagy OT - CIP2A OT - cancer OT - lysosomes OT - oncogene OT - proteolysis EDAT- 2017/04/15 06:00 MHDA- 2018/03/30 06:00 PMCR- 2018/03/02 CRDT- 2017/04/15 06:00 PHST- 2017/04/15 06:00 [pubmed] PHST- 2018/03/30 06:00 [medline] PHST- 2017/04/15 06:00 [entrez] PHST- 2018/03/02 00:00 [pmc-release] AID - 1293767 [pii] AID - 10.1080/15548627.2017.1293767 [doi] PST - ppublish SO - Autophagy. 2017 May 4;13(5):928-940. doi: 10.1080/15548627.2017.1293767. Epub 2017 Mar 2.